The unique issues of outpatient parenteral antimicrobial therapy in children and adolescents

Clinical Infectious Diseases

Volumn 51, Issue SUPPL. 2, 2010, Pages

  Rathore, Mobeen H ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ANTIBIOTIC THERAPY; APPENDICITIS; ARTHROCENTESIS; ARTHROTOMY; ASPIRATION; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BONE BIOPSY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILD HEALTH CARE; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH PROGRAM; HEART ARRHYTHMIA; HOSPITAL INFECTION; HUMAN; HYPOTENSION; INCISION; LIVER TOXICITY; NEUTROPENIA; OSTEOMYELITIS; OUTPATIENT CARE; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; PNEUMOTHORAX; PRIORITY JOURNAL; RASH; REVIEW; SURGICAL DRAINAGE; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR ACCESS;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CLINICAL TRIALS AS TOPIC; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; INFUSIONS, INTRAVENOUS; TREATMENT OUTCOME;

EID: 77957841252     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653521     Document Type: Review

References (49)

1. Hinckley J, Allen PJ. Community-associated MRSA in the pediatric primary care setting. Pediatr Nurs 2008; 34:64-71.
2. Bradley JS. Outpatient parenteral antibiotic therapy: management of serious infections. Part I: Medical, socioeconomic, and legal issues. Pediatric considerations. Hosp Pract (Off Ed) 1993; 28(suppl 1):28-32.
3. McDonald JR, Carriker CM, Pien BC, et al. Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread. Pediatr Infect Dis J 2007; 26:678-683.
4. David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis 2006; 12:631-637.
5. Benson L, Sprague B, Campos J, Singh N. Epidemiology of infection and colonization with vancomycin-resistant enterococci and frequency of cocolonization with methicillin-resistant Staphylococcus aureus in children. Infect Control Hosp Epidemiol 2007; 28:880-882.
6. Gutierrez K. Continuation of antibiotic therapy for serious bacterial infections outside of the hospital. Pediatr Ann 1996; 25:639-645.
7. Dagan R, Fliss DM, Einhorn M, Kraus M, Lieberman A. Outpatient management of chronic suppurative otitis media without cholesteatoma in children. Pediatr Infect Dis J 1992; 11:542-546.
8. Dagan R. How far can the paediatric patient with a serious infection be managed as an outpatient? J Hosp Infect 1995; 30(suppl):172-178.
9. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974; 54:358-360.
10. Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee. Clin Infect Dis 1997; 25:787-801.
11. Antoniskis A, Anderson BC, Van Volkinburg EJ, Jackson JM, Gilbert DN. Feasibility of outpatient self-administration of parenteral antibiotics.West J Med 1978; 128:203-206.
12. Stiver HG, Telford GO, Mossey JM, et al. Intravenous antibiotic therapy at home. Ann Intern Med 1978; 89:690-693.
13. Goldenberg RI, Poretz DM, Eron LJ, Rising JB, Sparks SB. Intravenous antibiotic therapy in ambulatory pediatric patients. Pediatr Infect Dis 1984; 3:514-517.
14. Maraqa NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Pediatr Orthop 2002; 22:506-510. (Pubitemid 34686489)
15. Kolyvas E, Ahronheim G, Marks MI, Gledhill R, Owen H, Rosenthall L. Oral antibiotic therapy of skeletal infections in children. Pediatrics 1980; 65:867-871. (Pubitemid 10068339)
16. Bradley JS, Behrendt CE, Arrieta AC, et al. Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. Pediatr Infect Dis J 2001; 20:19-24.
17. Esposito S, Noviello S, Ianniello F, D'Errico G. Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosa. J Chemother 2000; 12:88-93. (Pubitemid 30139833)
18. Einhorn M, Fliss DM, Leiberman A, Dagan R. Otolaryngology and infectious disease team approach for outpatient management of serious pediatric infections requiring parenteral antibiotic therapy. Int J Pediatr Otorhinolaryngol 1992; 24:245-251.
19. Waler, JA, Rathore MH. Outpatient management of pediatric bacterial meningitis. Pediatr Infect Dis J 1995; 14:89-92.
20. Bradley JS. Outpatient parenteral antibiotic therapy: management of serious infections. Part II: Amenable infections and models for delivery. Meningitis Hosp Pract (Off Ed) 1993; 28(suppl 2):15-19.
21. Powell KR, Mawhorter SD. Outpatient treatment of serious infections in infants and children with ceftriaxone. J Pediatr 1987; 110:898-901. (Pubitemid 17080440)
22. Steele R, Marcy S. Outpatient management of bacterialmeningitis. Pediatr Infect Dis J 1989; 8:258-260.
23. Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J 1988; 7:160-164.
24. Nelson JD. Options for outpatient management of serious infections. Pediatr Infect Dis J 1987; 6:603-606.
25. Gomez M, Maraqa N, Alvarez A, Rathore M. Complications of outpatient parenteral antibiotic therapy in childhood. Pediatr Infect Dis J 2001; 20:541-543. (Pubitemid 32428917)
26. Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila) 2007; 46:247-251.
27. Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr 1987; 111:28-33.
28. Kane RE, Jennison K, Wood C, Black PG, Herbst JJ. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol 1988; 4:84-89.
29. Gilbert J, Robinson T, Littlewood JM. Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child 1988; 63:512-517.
30. Strandvik B, Hjelte L, Malmborg AS, Widén B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr 1992; 81:340-344.
31. Shemesh E, Yaniv I, Drucker M, et al. Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Med Pediatr Oncol 1998; 30:95-100. (Pubitemid 128765923)
32. Hooker L, Kohler J. Safety, efficacy, and acceptability of home intravenous therapy administered by parents of pediatric oncology patients. Med Pediatr Oncol 1999; 32:421-426. (Pubitemid 29249742)
33. Wiernikowski JT, Rothney M, Dawson S, Andrew M. Evaluation of a home intravenous antibiotic program in pediatric oncology. Am J Pediatr Hematol Oncol 1991; 13:144-147.
34. Ingram C, Eron LJ, Goldenberg RI, et al. Antibiotic therapy of osteomyelitis in outpatients. Med Clin North Am 1988; 72:723-738.
35. Tice AD. Outpatient parenteral antimicrobial therapy for osteomyelitis. Infect Dis Clin North Am 1998; 12:903-919. (Pubitemid 29004654)
36. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003; 51:1261-1268. (Pubitemid 36622083)
37. Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr 1978; 92:485-490. (Pubitemid 8296517)
38. Green NE, Edwards K. Bone and joint infections in children. Orthop Clin North Am 1987; 18:555-576.
39. Reid S, Bonadio W. Feasibility of short-term outpatient intravenous antibiotic therapy for the management of infectious conditions in pediatric patients. Am J Emerg Med 2006; 24:839-842. (Pubitemid 44693144)
40. Prober CG, Yeager AS. Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis. J Pediatr 1979; 95:131-135.
41. Kao HC, Huang YC, Chin CH, et al. Acute hematogenous osteomyelitis and septic arthritis in children. J Microbiol Immunol Infect 2003; 36:260-265.
42. Zaoutis T, Localio AR, Leckerman K, et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 2009; 123:636-642.
43. Stovroff MC, Totten M, Glick PL. PIC lines save money and hasten discharge in the care of children with ruptured appendicitis. J Pediatr Surg 1994; 29:245-247.
44. Warner BW, Kulick RM, Stoops MM, Mehta S, Stephan M, Kotagal UR. An evidence-based clinical pathway for acute appendicitis decreases hospital duration and cost. J Pediatr Surg 1998; 33:1371-1375. (Pubitemid 28443112)
45. Firilas AM, Higginbotham PH, Johnson DD, Jackson RJ, Wagner CW, Smith SD. A new economic benchmark for surgical treatment of appendicitis. Am Surg 1999; 65:769-773. (Pubitemid 29344941)
46. American Academy of Pediatrics Committee on Infectious Diseases. Treatment of bacterial meningitis. Pediatrics 1988; 81:904-907.
47. Klein JO, Feigin RD, McCracken GH Jr. Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics 1986; 78:959-982.
48. Report of the Committee on Infectious Diseases. In: Red Book. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006.
49. Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999; 106:44-49. (Pubitemid 29077140)